> PDF: 9/11/2017 - AMCP submits comments on Draft CY2018 Medicare Part B Physician Fee Schedule urging CMS to critically evaluate coding & reimbursement options under Part B to ensure patient access and affordability of biologics and biosimilars, require
> PDF: 9/11/2017 - AMCP submits comments on Draft CY2018 Medicare Part B Physician Fee Schedule urging CMS to critically evaluate coding & reimbursement options under Part B to ensure patient access and affordability of biologics and biosimilars, require